• RegMed XB

    Regenerative Medicine Crossing Borders

  • Home
  • Terms & Conditions

Terms and Conditions

By agreeing to these terms you indicate you are employed by one of the RegMed XB signatory partners. As such you are bound by strict confidentiality as described in the consortium agreement.

This portal and all of its information and documents are confidential and/or proprietary information and is intended for RegMed XB consortium partners only. Any unauthorized use of the information contained herein (including, but not limited to, alteration, reproduction, communication, distribution or any other form of dissemination) is strictly prohibited. If you are not the employed by a RegMed XB consortium partner, please notify the RegMed XB office (This email address is being protected from spambots. You need JavaScript enabled to view it.) promptly and delete all obtained information/documents subsequently.

Please refer to the RegMed XB Phase 1 consortium agreement for the full Terms & Conditions

RegMed XB Consortium partners:

300MICRONS
Access2bone
Chemelot InSciTe
CytoSMART
Diabetesfonds Nederland
TU Eindhoven
Foundation RegMed XB
Fujifilm Manufacturing
Galapagos
Hartstichting
HCM-Medical
Innophysics

KU Leuven
Kuros
Leiden UMC
Leiden Regenerative Medicine Platform (LRMP)
Nierstichting
LifeTec Group
Maastricht University
Materiomics
Mimetas
Ncardia
Nestegg

NTrans
Osteo-Pharma
ReumaNederland
STENTiT
Stichting DON
Suprapolix
UMC Utrecht
Utrecht University
Veldlaser
Visualsonics
Xeltis
Other (event registration only)


  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner